WEBER leaves the Vivactis Group in line with the short-term strategy and reorganization process the Belgian holding company is implementing.
WEBER leaves the Vivactis Group in line with the short-term strategy and reorganization process the Belgian holding company is implementing. Madrid, the 3rd of July 2024 – At the end of June 2024, the VIVACTIS Group has decided to sell its entire stake in WEBER to Álvaro Hidalgo, one of its founders, as part of […]
Fundación Weber and EUPATI-ESPAÑA sign a collaboration framework agreement in order to support access to therapeutic innovation and contribute to improving the well-being of all citizens
This agreement will promote and monitor the impact of citizen participation throughout the development cycle of innovative therapies Based on a close and continuous collaboration between researchers and patient associations, it will be possible to propose real solutions to real needs. Matching with the World Day of Social Justice, this joint project between two organizations […]
Weber joins Vivactis Group to reinforce its Market Access capabilities
Brussels, the 2nd of February – Vivactis Group, the leading European healthcare consultancy group, announces its acquisition of Weber, a Market Access Consultancy firm and specialist in Health Economics and Outcomes Research (HEOR). The acquisition strengthens the Vivactis HM3A Market Access branch by expanding the reach in Market Access throughout Europe, as well as adding […]